Search Count: 15
 |
Organism: Macaca mulatta
Method: X-RAY DIFFRACTION Resolution:2.44 Å Release Date: 2024-02-07 Classification: IMMUNE SYSTEM Ligands: NAG, ZWV, SO4 |
 |
Organism: Macaca mulatta
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2024-02-07 Classification: IMMUNE SYSTEM Ligands: NAG, QEC, SO4 |
 |
Organism: Macaca mulatta
Method: X-RAY DIFFRACTION Resolution:3.14 Å Release Date: 2024-02-07 Classification: IMMUNE SYSTEM Ligands: NAG, SO4, QCX |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2022-02-09 Classification: IMMUNE SYSTEM Ligands: B7L |
 |
Crystal Structure Of The Human Brd2 Bd1 Bromodomain In Complex With 9-(Cyclopropylmethyl)-7-[(2R,6S)-2,6-Dimethylmorpholine-4-Carbonyl]-3-(3,5-Dimethyl-1,2-Oxazol-4-Yl)-9H-Carbazole-1-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2021-09-29 Classification: CELL CYCLE Ligands: YW1, EDO |
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With 9-Benzyl-2-(3,5-Dimethyl-1,2-Oxazol-4-Yl)-7-(2-Hydroxypropan-2-Yl)-9H-Carbazole-4-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2021-09-29 Classification: CELL CYCLE Ligands: YW4, EDO |
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With 2-(3,5-Dimethyl-1,2-Oxazol-4-Yl)-7-(2-Hydroxypropan-2-Yl)-9-[(S)-(Oxan-4-Yl)(Phenyl)Methyl]-9H-Carbazole-4-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2021-09-29 Classification: CELL CYCLE Ligands: YW7, EDO |
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With Bms-986158, 2-{3-(1,4-Dimethyl-1H-1,2,3-Triazol-5-Yl)-5-[(S)-(Oxan-4-Yl)(Phenyl)Methyl]-5H-Pyrido[3,2-B]Indol-7-Yl}Propan-2-Ol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2021-09-29 Classification: CELL CYCLE Ligands: YWA, IOD, EDO |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D) In Complex With 6-[1-(2,2-Difluoroethyl)-4-(6-Methylpyridin-2-Yl)-1H-Imidazol-5-Yl]Imidazo[1,2-A]Pyridine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2020-02-05 Classification: TRANSFERASE Ligands: QMY, GOL |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D) In Complex With 6-[4-(3-Chloro-4-Fluorophenyl)-1-(2-Hydroxyethyl)-1H-Imidazol-5-Yl]Imidazo[1,2-B]Pyridazine-3-Carbonitrile
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2020-02-05 Classification: TRANSFERASE Ligands: QMV, GOL |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D) In Complex With N-{4-[3-(6-Fluoropyridin-3-Yl)-4-Oxo-4,5,6,7-Tetrahydro-1H-Pyrrolo[3,2-C]Pyridin-2-Yl]Pyridin-2-Yl}Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2018-10-31 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: J2M, GOL |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D) In Complex With N-{4-[3-(6-Methoxypyridin-3-Yl)-1H-Pyrrolo[3,2-B]Pyridin-2-Yl]Pyridin-2-Yl}Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-10-31 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: J2V |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D) In Complex With N-{4-[3-(5-Methoxypyridin-2-Yl)-1H-Pyrrolo[3,2-B] Pyridin-2-Yl]Pyridin-2-Yl}Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2018-10-31 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: J2Y, GOL |
 |
Tgf-Beta Receptor Type 2 Kinase Domain In Complex With N- {4-[3-(6-Methoxypyridin-3-Yl)-1H-Pyrrolo[3,2-B]Pyridin-2- Yl]Pyridin-2-Yl}Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2018-10-31 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: J2V, MG, GOL |
 |
The Crystal Structure Of Echinococcus Granulosus Fatty-Acid-Binding Protein 1
Organism: Echinococcus granulosus
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2003-06-19 Classification: LIPID BINDING PROTEIN Ligands: PLM |